ULTIMO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 954
EU - Europa 357
AS - Asia 120
OC - Oceania 5
SA - Sud America 4
AF - Africa 1
Totale 1.441
Nazione #
US - Stati Uniti d'America 951
PL - Polonia 192
CN - Cina 73
IT - Italia 61
UA - Ucraina 27
SE - Svezia 25
TR - Turchia 23
DE - Germania 19
GB - Regno Unito 18
VN - Vietnam 17
FI - Finlandia 6
AU - Australia 5
BE - Belgio 4
BR - Brasile 3
CA - Canada 3
TW - Taiwan 3
IE - Irlanda 2
RO - Romania 2
CL - Cile 1
ES - Italia 1
IN - India 1
JP - Giappone 1
NG - Nigeria 1
PH - Filippine 1
TH - Thailandia 1
Totale 1.441
Città #
Warsaw 192
Fairfield 161
Woodbridge 113
Houston 92
Ann Arbor 83
Ashburn 78
Cambridge 70
Seattle 60
Chandler 59
Wilmington 52
Jacksonville 38
Ferrara 21
Izmir 21
Dong Ket 17
Nanjing 15
Beijing 14
Princeton 12
Shanghai 11
Boardman 10
Hebei 6
Nanchang 6
San Diego 6
London 5
Shenyang 5
Brussels 4
Cagliari 4
Milan 4
Albuquerque 3
Changsha 3
Dearborn 3
Taipei 3
Tianjin 3
Bologna 2
Casnate Con Bernate 2
Des Moines 2
Focsani 2
Hangzhou 2
Mainz 2
Melbourne 2
Munich 2
New York 2
Tappahannock 2
Trieste 2
Wuhan 2
Adelaide 1
Auburn Hills 1
Bangkok 1
Braintree 1
Chicago 1
Dublin 1
Falls Church 1
Fuzhou 1
Greenwich 1
Helsinki 1
Jinan 1
Kunming 1
Lanzhou 1
Liberty 1
Norwalk 1
Orange 1
Phoenix 1
Pune 1
Redmond 1
San Mateo 1
Serra 1
Xian 1
Zhengzhou 1
Totale 1.221
Nome #
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 162
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 157
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 146
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 144
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 140
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 138
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 138
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 135
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 123
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 106
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 104
Inhibition of the PI3K/Akt/mTOR signaling pathway as a therapeutic target for Acute Lymphoblastic Leukemia 19
Totale 1.512
Categoria #
all - tutte 4.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019125 0 0 0 0 0 0 0 0 0 0 51 74
2019/2020326 42 12 16 49 26 38 31 31 34 15 14 18
2020/2021499 12 17 19 20 102 62 58 51 27 84 15 32
2021/2022105 9 5 1 1 11 12 3 2 6 19 16 20
2022/2023141 13 6 13 18 17 29 7 10 17 1 5 5
2023/202447 7 9 1 3 1 4 4 10 2 4 2 0
Totale 1.512